drugset

drugset / Trial / NCT00672373

Extract of Ginkgo Biloba and Tardive Dyskinesia

NCT00672373 ↗

Phase 3 Completed 157 enrolled Beijing HuiLongGuan Hospital Peking University · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether Extract of Ginkgo Biloba is effective in the treatment on Tardive dyskinesia

Timeline

Start: 2006-12
Primary completion: 2007-05
Completion: 2007-08

Publications

Zhang WF, Tan YL, Zhang XY, Chan RC, Wu HR, Zhou DF. Extract of Ginkgo biloba treatment for tardive dyskinesia in schizophrenia: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2011 May;72(5):615-21. doi: 10.4088/JCP.09m05125yel. Epub 2010 Sep 21.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Extract of Ginkgo Biloba	Unknown	80 mg	Oral

Indications